In diesem Working Paper werden räumliche Reorganisationstrends von Forschung und Entwicklung in der Medizintechnik betrachtet. In Deutschland ansässige medizintechnische Großunternehmen sehen sich einem wachsenden Druck ausgesetzt, internationale Wissensressourcen und Marktsegmente zu...

In diesem Working Paper werden räumliche Reorganisationstrends von Forschung und Entwicklung in der Medizintechnik betrachtet. In Deutschland ansässige medizintechnische Großunternehmen sehen sich einem wachsenden Druck ausgesetzt, internationale Wissensressourcen und Marktsegmente zu...

This paper concerns China's market for medical technologies and how the Chinese state is assisting its own companies to gain greater sales at the expense of producers from Europe and other advanced manufacturing economies. The medical technology sector captures a variety of products, services...

Aunque el creciente apoyo de los miembros de la OMC a una propuesta de exención de determinadas obligaciones en virtud del Acuerdo sobre los ADPIC con respecto a los productos sanitarios necesarios para responder a la COVID-19 ha hecho que sea inminente una decisión sobre la exención de los...

Innovation is part idea generation and part development. We build a model of "innovating-by-doing," whereby ideas come to practitioners. Successful innovation requires that practitioners' ideas be developed through costly effort. Our model nests existing theories of laboratory research and...

We investigated the role of public funding in cardiovascular device innovation across 31 countries in Europe. We rely on the knowledge production function (KPF) framework that establishes the knowledge output of a region as a function of innovatory effort and other characteristics of that...

This paper concerns China's market for medical technologies and how the Chinese state is assisting its own companies to gain greater sales at the expense of producers from Europe and other advanced manufacturing economies. The medical technology sector captures a variety of products, services...

In wirtschaftlicher und beschäftigungspolitischer Hinsicht ist die Medizintechnik eine wachstumsstarke Branche, die von einem intensiven Innovations- und Qualitätswettbewerb geprägt ist. Die nach wie vor starke Stellung der Branche auf dem Weltmarkt zeigt, dass Deutschland ein guter...

Increasing demand for modern treatments and significant profit margins are strong incentives for investors and producers. However, the production and use of medical devices is subject to a number of laws, regulations, strict standards, and certification processes. Therefore, the aim of this...

Die Medizintechnik ist eine sehr heterogene, wachstumsstarke Branche, die von einem intensiven Innovations- und Qualitätswettbewerb geprägt ist. Die starke Stellung der Branche auf dem Weltmarkt zeigt, dass Deutschland ein guter Innovations- und Produktionsstandort für die Medizintechnik ist....

The availability of medical equipment contributes significantly to the stability and sustainability of health care systems. However, in some countries, especially the developing ones, medical equipment availability is a major issue that remains unsolved. Hence, this paper explores the root...

We analyze wartime prosthetic device patents to investigate how demand and procurement policy can shape medical innovation. We use machine learning tools to develop new data describing the aspects of medical and mechanical innovations that are emphasized in patent documents. Our analysis of...

Ein Gutachten des IfW Kiel im Auftrag der IMPULS-Stiftung des VDMA zeigt: Deutschlands Wohlstand wird entscheidend von der internationalen Arbeitsteilung getragen. Erschwert Deutschland in Reaktion auf die Coronakrise die Kooperation mit ausländischen Lieferanten, etwa um Lieferketten durch das...

"Key Account Management Excellence in Pharma & Medtech is designed to help life sciences practitioners develop and execute innovative and effective key account management (KAM) strategies and capabilities. Pharmaceutical and medtech companies are increasingly pursuing KAM in response to the...

Prior research has shown that some patients and caregivers such as relatives are innovating in relation to their unmet medical needs. However, there is little evidence whether and how these ideas are later implemented into market-ready solutions and subsequently commercialized. We analyze cases...

This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the administrative hurdle of securing permanent, reimbursable...

We draw upon newly merged administrative data sets to study the relationship between payments from medical technology firms to physicians and medical device procurement by hospitals. These payments (and the interactions that accompany them) may facilitate the transfer of valuable information to...

The adoption of healthcare technology is central to improving productivity in this sector. To provide new evidence on how technology affects healthcare markets, we focus on one area where adoption has been particularly rapid: surgery for prostate cancer. Over just six years, robotic surgery grew...

When firms span related product categories, spillovers across categories become central to firm strategy and industrial policy, due to their potential to foreclose competition and affect innovation incentives. We exploit major new product innovations in one medical device category, and detailed...

When firms span related product categories, spillovers across categories become central to firm strategy and industrial policy, due to their potential to foreclose competition and affect innovation incentives. We exploit major new product innovations in one medical device category, and detailed...

This paper explores how the regulatory approval process affects innovation incentives in medical technologies. Prior studies have found early mover regulatory advantages for drugs. I find the opposite for medical devices, where pioneer entrants spend 34 percent (7.2 months) longer than follow-on...